Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02028195|
Recruitment Status : Unknown
Verified September 2018 by Annelli Sandbæk, University of Aarhus.
Recruitment status was: Enrolling by invitation
First Posted : January 7, 2014
Last Update Posted : October 1, 2018
|Condition or disease||Intervention/treatment||Phase|
|Health Promotion Cardiovascular Disease Physical Inactivity Selfreported Quality of Health Mental Health||Other: Health check||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||11000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The CORE-trial: a Pragmatic Randomized Controlled Trial in Primary Care Investigating Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme Offered Population-wide to 30-49 Years|
|Study Start Date :||May 2013|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2019|
Experimental: Health check
The intervention consists of invitation for a behavioural and clinical examination followed by either (I) referral to a health promoting consultation in general practice (II) targeted behavioural programmes at the local Health Centre or (III ) no need for follow-up.
Other: Health check
The program includes four components:
Invitation: All participants receive invitation by mail and a prefixed appointment time. A web-based questionnaire including self-reported health (SF12), physical activity, smoking habits and alcohol use/behaviour has to be answered before Health Examination (HE).
The HE include: Blood pressure, waist, weight, lung function test, lipid profile, HbA1c and fitness (Aastrand).
Health profile pamphlet: The participant receives a pamphlet with the results. The persons are stratified into three groups (I) referral to a consultation in general practice (GP) (II) targeted behavioural programs at the health centre (HC) or (III ) no identified need for health promoting follow-up.
Follow-up according to risk-profile: If referred to GP treatment of risk conditions or diseases will follow national guidelines. The GPs were paid 50 Euros per health interview.
No Intervention: No invitation
The persons randomised to the control arm does not get invitation to a health care examination before time for follow up in the intervention group.
- Physical activity [ Time Frame: 4 years ]Physical activity level will be measured by 1) self-reported physical activity (days/week with minimum 30 minutes moderate physical activity) and 2) physical fitness, measured by Aastrands submaximal bike-test.
- Modelled cardiovascular risk [ Time Frame: 4 years ]Cardiovascular risk will be measured as a modelled risk of developing cardiovascular disease within 10 years and includes information on age, gender, smoking status, systolic blood pressure and total cholesterol.
- Health related quality of life [ Time Frame: 4 years ]Health related quality of life measured by The Medical Outcome Study Short Form 12 Health Survey (SF12)
- Functional capacity [ Time Frame: 4 years ]Functional capacity will be measured as affiliation to the labor market (work participation in the last year)and sick leave > 3 weeks.
- Health economy assessment [ Time Frame: 4 years ]The economic benefits of the interventions will be assessed by comparing mean direct and total costs (direct and productivity costs), and expected life years gained (LYG) in the intervention group with the control group (within a period of four.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02028195
|Department of Public Health|
|Aarhus, Denmark, 8000|
|Principal Investigator:||Annelli Sandbæk, Professor||University of Aarhus|
|Principal Investigator:||Helle T Maindal, Professor||University of Aarhus|